Generic Name and Formulations:
Doripenem (as monohydrate) 250mg/vial, 500mg/vial; pwd for IV infusion after constitution and dilution; preservative-free.
Indications for DORIBAX:
Susceptible complicated intra-abdominal and complicated urinary tract infections (including pyelonephritis).
Give by IV infusion over 1hr; may switch to oral antibiotics after 3 days. ≥18yrs (CrCl >50mL/min): Intra-abdominal: 500mg every 8hrs for 5–14 days. UTI, pyelonephritis: 500mg every 8hrs for 10–14 days. CrCl 30–50mL/min: 250mg every 8hrs; CrCl>10–<30mL/min: 250mg every 12hrs.
<18yrs: not established.
Not for treatment of ventilator-associated bacterial pneumonia. Carbapenems, cephalosporins, penicillins or other allergy. Discontinue if serious hypersensitivity reactions occur and treat. Increased risk of seizures with history of CNS disorders (eg, stroke), renal dysfunction, or doses >500mg every 8hrs. Risk of pneumonitis with inhalational use; avoid this route. Renal impairment; monitor. Pregnancy (Cat.B). Nursing mothers.
Antagonizes valproic acid; if needed, monitor and consider supplemental anticonvulsant. Potentiated by probenecid: not recommended.
Headache, nausea, diarrhea (may be serious; evaluate if occurs), rash, phlebitis, anemia, elevated hepatic enzymes; C. difficile-associated diarrhea, hypersensitivity reactions, seizures.
Single-use vials—1, 10
Clinical Pain Advisor Articles
- FDA Takes Steps to Reconcile Needs of Patients With Chronic Pain, Efforts to Curb Opioid Epidemic
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Neuropathic Symptoms Worsen Quality of Life, Function in Hip, Knee Osteoarthritis
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- Switching From Buprenorphine-Naltrexone to XR-Naltrexone as Effective as XR-Naltrexone
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Human Diagnosis Project Aims to Address Challenges Among Uninsured
- Healthcare Technology Affects Younger Patient Satisfaction
- FDA Announces New Drug Shortages Task Force